Subscribe to Biological Therapies in Psychiatry -  Choose your plan >
IN THIS MONTH'S ISSUE:
May 2015

Intranasal Ketamine for MDD
An intranasal application of ketamine could be an easier and more practical means to deliver this rapid-acting agent for patients with major depressive disorder.

Smoking and Erectile Dysfunction
A meta-analysis found a positive dose-response association between both the quantity and duration of smoking and the risk that a patient developed erectile dysfunction.

Statins and Depression Risk
Results from a study of statin use in patients with depression support other evidence that this widely used class of drugs may protect brain health.

A Single Elevated Lithium Level Can Impact Renal Function
In almost 700 lithium-treated patients, a single lithium level greater than 1.0 mmol/L was associated with a significant decrease in estimated glomerular filtration rate (eGFR) for at 3 months.

In Brief
FDA Cautions Against Using Testosterone Products for Low Testosterone Levels Due to Aging; Weight Loss Supplement Contains Hidden Fluoxetine

Antipsychotics in PTSD
Many veterans are treated off-label with antipsychotics for post-traumatic stress disorder (PTSD) despite a lack of evidence for their efficacy.

Search

Current Issue

View the current issue, or choose from the search criteria below.


Search by Issue


If you need an issue previous to 2000, contact our staff or call us at 800-700-9589.

Search by Keywords


(For example, enter: depression or weight gain in the text area, then click SEARCH.)